Literature DB >> 21287182

Fibrotic response of tissue remodeling in COPD.

Lina María Salazar1, Ana Milena Herrera.   

Abstract

Lung tissue remodeling in chronic obstructive pulmonary disease (COPD) involves diverse processes characterized by epithelial disruption, smooth muscle hypertrophy/hyperplasia, airway wall fibrosis, and alveolar destruction. According to the accepted current theory of COPD pathogenesis, tissue remodeling in COPD is predominantly a consequence of an imbalance between proteolytic and antiproteolytic activities. However, most of the studies carried out during the last few years have focused on mechanisms related to degradation of extracellular matrix (ECM) structural proteins, neglecting those involved in ECM protein deposition. This review revisits some of the latest findings related to fibrotic changes that occur in the airway wall of COPD patients, as well as the main cellular phenotypes relevant to these processes.

Entities:  

Mesh:

Year:  2011        PMID: 21287182     DOI: 10.1007/s00408-011-9279-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  106 in total

Review 1.  New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies.

Authors:  Mitchell A Watsky; Karl T Weber; Yao Sun; Arnold Postlethwaite
Journal:  Int Rev Cell Mol Biol       Date:  2010-06-18       Impact factor: 6.813

2.  Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia.

Authors:  Vasiliy V Polosukhin; William E Lawson; Aaron P Milstone; Svetlana M Egunova; Andrey G Kulipanov; Sergey G Tchuvakin; Pierre P Massion; Timothy S Blackwell
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

Review 3.  Extracellular matrix, integrins, and mesenchymal cell function in the airways.

Authors:  Darren J Fernandes; John V Bonacci; Alastair G Stewart
Journal:  Curr Drug Targets       Date:  2006-05       Impact factor: 3.465

4.  Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposure.

Authors:  Andrew Churg; Steven Zhou; Olena Preobrazhenska; Hsin Tai; Rona Wang; Joanne L Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Altered fibroblast proteoglycan production in COPD.

Authors:  Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif T Eriksson; Jonas S Erjefält; Claes-Göran Löfdahl; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2010-05-11

7.  Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition.

Authors:  Peng Qu; Hong Du; Xi Wang; Cong Yan
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

8.  Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population.

Authors:  H Schirmer; L Basso da Silva; P J Z Teixeira; J S Moreira; A L S Moreira; D Simon
Journal:  Genet Mol Res       Date:  2009-08-25

9.  Lung elastic recoil does not correlate with pulmonary hemodynamics in severe emphysema.

Authors:  Jeremy A Falk; Ubaldo J Martin; Steven Scharf; Gerard J Criner
Journal:  Chest       Date:  2007-10-01       Impact factor: 9.410

10.  MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.

Authors:  Gillian E Lowrey; Neil Henderson; John D Blakey; Jonathan M Corne; Simon R Johnson
Journal:  Respir Med       Date:  2008-03-06       Impact factor: 3.415

View more
  29 in total

1.  Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).

Authors:  Harjit Chahal; Susan R Heckbert; R Graham Barr; David A Bluemke; Aditya Jain; Mohammadali Habibi; Alvaro Alonso; Richard Kronmal; David R Jacobs; Joao A C Lima; Karol E Watson; Kiang Liu; Lewis J Smith; Philip Greenland
Journal:  Am J Cardiol       Date:  2015-03-24       Impact factor: 2.778

2.  The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.

Authors:  A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro
Journal:  Br J Pharmacol       Date:  2016-10-12       Impact factor: 8.739

Review 3.  Cellular senescence: from physiology to pathology.

Authors:  Daniel Muñoz-Espín; Manuel Serrano
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

4.  Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.

Authors:  Vasiliy V Polosukhin; Amber L Degryse; Dawn C Newcomb; Brittany R Jones; Lorraine B Ware; Jae Woo Lee; James E Loyd; Timothy S Blackwell; William E Lawson
Journal:  Exp Lung Res       Date:  2012-04       Impact factor: 2.459

5.  Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease.

Authors:  Carlos A Barrero; Oscar Perez-Leal; Mark Aksoy; Camilo Moncada; Rong Ji; Yolanda Lopez; Karthik Mallilankaraman; Muniswamy Madesh; Gerard J Criner; Steven G Kelsen; Salim Merali
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

Review 6.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

7.  Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells.

Authors:  Xiaobo Zhou; Weiliang Qiu; J Fah Sathirapongsasuti; Michael H Cho; John D Mancini; Taotao Lao; Derek M Thibault; Augusto A Litonjua; Per S Bakke; Amund Gulsvik; David A Lomas; Terri H Beaty; Craig P Hersh; Christopher Anderson; Ute Geigenmuller; Benjamin A Raby; Stephen I Rennard; Mark A Perrella; Augustine M K Choi; John Quackenbush; Edwin K Silverman
Journal:  Genomics       Date:  2013-03-01       Impact factor: 5.736

8.  Cigarette Smoke Induces Human Epidermal Receptor 2-Dependent Changes in Epithelial Permeability.

Authors:  Rangnath Mishra; Daniel Foster; Vihas T Vasu; Jyoti V Thaikoottathil; Beata Kosmider; Hong Wei Chu; Russell P Bowler; James H Finigan
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

9.  Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease.

Authors:  Yuan Zhan; Jinkun Chen; Jixing Wu; Yiya Gu; Qian Huang; Zhesong Deng; Shanshan Chen; Xiaojie Wu; Yongman Lv; Zhilin Zeng; Jungang Xie
Journal:  Respir Res       Date:  2022-05-12

10.  Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring.

Authors:  Taotao Lao; Kimberly Glass; Weiliang Qiu; Francesca Polverino; Kushagra Gupta; Jarrett Morrow; John Dominic Mancini; Linh Vuong; Mark A Perrella; Craig P Hersh; Caroline A Owen; John Quackenbush; Guo-Cheng Yuan; Edwin K Silverman; Xiaobo Zhou
Journal:  Genome Med       Date:  2015-02-14       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.